For the Inventor, By the Inventor

Enter assignee name

Coralville, IA, United States of America

Integrated Dna Technologies, Inc.

USPTO Granted Patents = 111

% Expired Patents = 9.0

CIPO Patents = 3

EPO Patents = 26

Trademarks = 30

Forward Citations = 541

Loading Chart...

Loading Chart...

103 inventors (with patents filed for the assignee):

Mark Aaron Behlke (75 out of 84 patents)

Joseph Alan Walder (36 out of 41 patents)

Christopher Anthony Vakulskas (20 out of 20 patents)

4. Michael Allen Collingwood (18 out of 18 patents)

5. Scott Rose (17 out of 17 patents)

6. Garrett Richard Rettig (14 out of 14 patents)

7. John J Rossi (13 out of 102 patents)

8. Dongho Kim (13 out of 19 patents)

9. Andrei Laikhter (12 out of 15 patents)

10. Joseph R Dobosy (11 out of 11 patents)

11. Yawfui Yong (11 out of 11 patents)

12. Richard Owczarzy (10 out of 13 patents)

13. Shawn Allen (9 out of 9 patents)

14. Lingyan Huang (8 out of 11 patents)

15. Mirna Jarosz (6 out of 49 patents)

Core Competencies:

CRISPR

DNA Polymerase

Reverse Transcriptase

NGS Library

Genome Editing

Aptamers

Cas9 Mutants

Oligonucleotide Synthesis

Hybridization Capture

RNA Assays

Template Discrimination

Gene Expression

111 patents: Sort by Forward Citations

1. 12741995 - UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR (2026-09-22),

2. 12723264 - S PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME (2026-09-01),

3. 12655422 - METHODS AND COMPOSITIONS FOR INHIBITION OF CRISPR RE-CLEAVAGE EVENTS (2026-06-16),

4. 12618054 - CRISPR/CPF1 SYSTEMS AND METHODS (2026-05-05),

5. 12577569 - APTAMERS FOR THE REVERSIBLE INHIBITION OF DNA POLYMERASES (2026-03-17),

6. 12559734 - Reverse Transcriptase Mutants with Increased Activity and Thermostability (2026-02-24),

7. 12459968 - Oligonucleotide synthesis on solid support (2025-11-04),

8. 12454684 - Methods using novel CPF1 mutations that enhance the DNA cleavage activity ofsp. CPF1 (2025-10-28),

9. 12435324 - sp. Cas12a mutants with enhanced cleavage activity at non-canonical TTTT protospacer adjacent motifs (2025-10-07),

10. 12435318 - Reverse transcriptase mutants with increased activity and thermostability (2025-10-07),

11. 12371731 - Normalization of NGS library concentration (2025-07-29),

12. 12365937 - Asymmetric targeted amplification methods (2025-07-22),

13. 12351799 - S. pyogenes CAS9 mutant genes and polypeptides encoded by same (2025-07-08),

14. 12297435 - Mutations inCas9 discovered by broad scanning mutagenesis demonstrate enhancement of DNA cleavage activity (2025-05-13),

15. 12264342 - ND2006 CAS12A mutant genes and polypeptides encoded by same (2025-04-01),

Company Overview

Integrated DNA Technologies, Inc. is a leader in the field of CRISPR technology, specializing in the development and manufacturing of innovative tools for genomic research and applications. The company focuses on key areas such as DNA polymerase, reverse transcriptase, and next-generation sequencing (NGS) library preparation, enabling advancements in genome editing and molecular biology. Located in Coralville, Iowa, IDT is committed to providing high-quality oligonucleotide synthesis and supporting the scientific community with cutting-edge solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

111 Patents

#1 in Coralville, IA

#23 in Iowa

#3,458 in US

#7,114 in the World

Coralville, IA, United States of America

Integrated Dna Technologies, Inc.

Forward Citations = 541

103 inventors:

Mark Aaron Behlke (75 out of 84 patents)

Joseph Alan Walder (36 out of 41 patents)

Christopher Anthony Vakulskas (20 out of 20 patents)

4. Michael Allen Collingwood (18 out of 18 patents)

5. Scott Rose (17 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Integrated Dna Technologies, Inc.. Retrieved from https://idiyas.com/company/integrated-dna-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…